T
Therapixel
Health Tech & Medtech · Paris, France · Founded 2013
Software company specialized in artificial intelligence for medical image analytics MoreLess
Therapixel is a French software company operating in the medical imaging and artificial intelligence sector. It was founded in 2013 by Olivier Clatz and Pierre Fillard.
Clatz and Fillard, both researchers with PhDs in medical image analysis, leveraged their extensive academic and research backgrounds to establish the company. Their journey began at Inria, the French National Institute for Research in Digital Science and Technology, and Asclepios, a project-team focused on the analysis and simulation of biomedical images. This foundation in deep-tech and medical imaging research directly shaped Therapixel's trajectory.
Initially, the company focused on developing Fluid, a touchless image navigation software for operating rooms. This system allowed surgeons to access and manipulate medical images using gesture control, thereby maintaining a sterile environment. However, a significant pivot occurred after the company's algorithm won the global Digital Mammography DREAM Challenge in 2017. This achievement, which benchmarked their AI against 1,200 others in identifying cancerous lesions in mammograms, redirected the company's focus towards breast cancer screening.
The company's core product is MammoScreen®, an AI-powered software designed to assist radiologists in interpreting mammograms. The software analyzes mammograms and assigns a suspicion score, ranging from 1 to 10, to indicate the probability of malignancy for each finding. This tool aims to improve the accuracy and efficiency of breast cancer detection, helping to reduce the number of false negatives and alleviate the workload of radiologists. MammoScreen integrates with existing Picture Archiving and Communication Systems (PACS) used by healthcare providers.
Therapixel's business model is centered on selling its software solution to hospitals, clinics, and imaging centers. The company has secured regulatory approvals, including CE marking in Europe and FDA clearance in the United States, allowing it to commercialize its product in these key markets. Its client base consists of healthcare providers specializing in radiology and breast imaging.
Keywords: medical imaging, artificial intelligence, breast cancer screening, radiology software, digital health, FDA clearance, CE mark, mammography, medical diagnostics, healthtech
Company overview
Therapixel company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2013
- Headquarters
- Paris, France
- Employees
- 61
- Open positions
- None listed
- Dealroom signal
- 85.3
Valuation & funding
Therapixel funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | May 2022 | $17M | $66M | Sham · CapHorn · Crédit Mutuel Innovation · Elaia | ↗ |
| SEEDEquity / VC | Jun 2021 | $4.2M | $17M | Undisclosed | — |
| EARLY VC✓Equity / VC | Mar 2019 | $5.5M | $22M | Omnes Capital · M Capital Partners | ↗ |
| SEED✓Equity / VC | Nov 2015 | $660K | $2.6M | Région Sud Investissement · IT-Translation · Conseil Plus Gestion | — |
| SPINOUT✓Other financing | Dec 2013 | $0 | — | INRIA | — |
| SUPPORT PROGRAM✓Other financing | Oct 2011 | HEC Challenge+ · HEC Paris | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
Growth signals
Therapixel website traffic
Latest recorded traffic for Therapixel is 4.4K monthly website visits, up 300% over the last three months. Therapixel's team grew 1.7% over the past year.
Comparisons
Therapixel compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Therapixel's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Therapixel has talent and traffic
team presence
In the news
Latest news about Therapixel
Recent press, funding announcements, and product moves mentioning Therapixel — open to read from the original sources.
Market sentiment
What the market is saying about Therapixel
An AI-synthesized read of the highest-engagement posts about Therapixel on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Therapixel’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.